ArticleEuropean journal of medical research2026
Neutrophil-to-albumin ratio and all-cause mortality in critically ill patients with cerebral infarction: a retrospective cohort study using the MIMIC-IV database.
Article in European journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Establishment and evaluation of a novel tool based on inflammation-nutrition derived biomarkers for early diagnosis of diabetic foot ulcers.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe neutrophil percentage-to-albumin ratio (NPAR) has been linked to outcomes in cardiovascular disease, yet its prognostic value in cerebral infarction (CI) remains unknown. This study investigates the association between NPAR and all-cause mortality in critically ill CI patients.
methodsData from 2338 CI patients (MIMIC-IV database) were stratified into NPAR tertiles (T1: < 20.975, T2: 20.975-26.888, and T3: ≥ 26.888). Primary endpoints included ICU, 30-, 90-, and 365-day mortality. Survival analysis used Kaplan-Meier curves and multivariable Cox regression. Restricted cubic splines (RCS) tested nonlinear associations, and subgroup analyses assessed consistency across clinical subgroups.
resultsMortality rates were 12.45% (ICU), 25.15% (30 days), 33.40% (90 days), and 43.54% (365 days). Higher NPAR was associated with worse survival (all log-rank p < 0.001). Adjusted Cox models showed T3 vs. T1 increased 30-day, 90-day, and 365-day mortality risk. RCS revealed nonlinear relationships (P-nonlinearity < 0.01), with an inflection point at NPAR = 23.6. Subgroup analyses showed consistent associations across sex, comorbidities, and severity scores, except age, which modified ICU mortality risk.
conclusionsHigher NPAR levels are independently associated with increased short- and long-term all-cause mortality in critically ill CI patients. NPAR may serve as a practical and accessible prognostic marker for risk stratification in the ICU.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.